Raimar Löbenberg

Raimar Löbenberg

Fondatore presso BIONXT SOLUTIONS INC.

Patrimonio netto: 1 M $ in data 30/06/2026

60 anni
Consumer Services
Health Technology
Commercial Services

Profilo

Raimar Löbenberg is the founder of RS Therapeutics, Inc., founded in 2018, serving as Chief Scientific Officer since 2018.
Dr. Löbenberg is the founder of BioNxt Solutions, Inc., founded in 2017, serving as Independent Director since 2018.
Current jobs include Director-Drug Development & Innovation Center at the University of Alberta since 2000 and Co-Managing Director at Vektor Pharma TF GmbH.
Former jobs include Independent Chairman at Defence Therapeutics Inc and President of the Canadian Society for Pharmaceutical Sciences from 2014 to 2015.
Education includes a doctorate from Johann Wolfgang Goethe-Universität Frankfurt am Main and an undergraduate degree from The Johannes Gutenberg University of Mainz.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
29/09/2025 5.040.000 ( 3,88% ) 1 M $ 30/06/2026

Posizioni attive di Raimar Löbenberg

SocietàPosizioneInizio
BIONXT SOLUTIONS INC. Fondatore 12/12/2017
Corporate Officer/Principal 01/01/2000
RS Therapeutics, Inc.
Fondatore 01/11/2018
Amministratore Delegato -

Precedenti posizioni note di Raimar Löbenberg

SocietàPosizioneFine
Presidente 01/01/2015
DEFENCE THERAPEUTICS INC. Presidente -
Vedi nel dettaglio l'esperienza di Raimar Löbenberg

Formazione di Raimar Löbenberg

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

86

Relazioni di 1° grado

8

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private8

Consumer Services

Consumer Services

Consumer Services

Commercial Services

Health Technology

RS Therapeutics, Inc.

Health Technology

Health Technology

  1. Mercati
  2. Insiders
  3. Raimar Löbenberg